Rizvi, Hira <br/><br/>
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  03 2018 
 - 633-641 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.75.3384  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B7-H1 Antigen--antagonists & inhibitors<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mutation<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Tumor Burden<br/>Exome Sequencing